IP Library Granted Patent US 7,338,781
Granted Patent B2
US 7,338,781 · App. 10/548,420 · Granted Mar 4, 2008

Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,338,781
App. No.
10/548,420
Granted
Mar 4, 2008
Kind
B2
Abstract

The present invention is directed to a polynucleotide sequence of a novel organic anion transporting (OAT)-like protein UST3-likel. More particularly, the present invention provides a polynucleotide sequence comprising the nucleic acid sequence SEQ ID NO: 1 or nucleic acid sequences that hybridize to SEQ ID NO: 1 or its complimentary strand. The invention also provides the human UST3-LIKE1 associated with the gastrointestinal and liver diseases, metabolic diseases, hematological disorders, respiratory diseases, neurological disorders, urological disorders and cardiovascular diseases as a result of relative quantification of the mRNA distribution in different human tissues by expression profiling. The invention also provides assays for the identification of compounds useful for the modulation of said diseases. The methods of the invention involve cell-free and cell-based assays that identify compounds which bind to and/or activate or inhibit the activity of UST3-LIKE1, a organic anion transporting (OAT)-like protein, followed by an in vivo assay of the effect of the compound on said diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of UST3-LIKE1 as well as pharmaceutical compositions comprising such compounds.

Claims (19)

1. An isolated nucleic acid molecule encoding an UST3-LIKE 1 polypeptide comprising the amino acid sequence of SEQ ID NO:2,

wherein the polypeptide encoded by said nucleic acid molecule has UST3-LIKE1 activity.

2. A vector comprising the nucleic acid molecule of claim 1 .

3. An isolated host cell containing the vector of claim 2 .

4. A method of producing a UST3-LIKE 1 polypeptide comprising the steps of

i) culturing the host cell of claim 2 under suitable conditions and

ii) recovering the UST3-LIKE 1 polypeptide from the culture medium.

5. The nucleic acid molecule of claim 1 which comprises the sequence of SEQ ID NO: 1.

6. A vector comprising the nucleic acid molecule of claim 5 .

7. An isolated host cell containing the vector of claim 6 .

8. A method of producing a UST3-LIKE 1 polypeptide comprising the steps of

i) culturing the host cell of claim 7 under suitable conditions and

ii) recovering the UST3-LIKE 1 polypeptide from the culture medium.

9. The isolated nucleic acid molecule of claim 5 which consists of the sequence of SEQ ID NO: 1.

10. A vector comprising the nucleic acid molecule of claim 9 .

11. An isolated host cell containing the vector of claim 10 .

12. A method of producing a UST3-LIKE 1 polypeptide comprising the steps of

i) culturing the host cell of claim 11 under suitable conditions and

ii) recovering the UST3-LIKE 1 polypeptide from the culture medium.

Assignments (2)
MERGER Recorded Feb 19, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022277/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2006
From: GOLZ, STEFAN; BRUGGEMEIER, ULF; GEERTS, ANDREAS
To: BAYER HEALTHCARE AG
Reel/Frame 017989/0044 →